SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-014584
Filing Date
2022-04-14
Accepted
2022-04-14 16:16:52
Documents
4
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20002052x1_def14a.htm DEF 14A 1978970
2 ny20002052x1-pc01.jpg GRAPHIC 644747
3 ny20002052x1-pc02.jpg GRAPHIC 814499
4 sig_kellymacdonald.jpg GRAPHIC 13057
  Complete submission text file 0001140361-22-014584.txt   4006890
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 22827472
SIC: 2834 Pharmaceutical Preparations